Taysha Gene Therapies, Inc. · NASDAQ:TSHA

Morgan Stanley reported a 5.10% stake in Taysha Gene Therapies, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Morgan Stanley reported a 5.10% stake in Taysha Gene Therapies, Inc., 16,244,339 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
5.10%
Shares
16,244,339
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley5.10%16,244,339
Morgan Stanley Capital Services LLC5.00%16,001,130

Source

View original at SEC

Related